UBS OCONNOR LLC - CONNECT BIOPHARMA HLDGS LTD ownership

CONNECT BIOPHARMA HLDGS LTD's ticker is CNTB and the CUSIP is 207523101. A total of 30 filers reported holding CONNECT BIOPHARMA HLDGS LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
UBS OCONNOR LLC ownership history of CONNECT BIOPHARMA HLDGS LTD
ValueSharesWeighting
Q3 2023$468,626
-30.1%
603,9000.0%0.01%
-42.9%
Q2 2023$670,329
+16.8%
603,900
+5.2%
0.02%
+16.7%
Q1 2023$574,148
-99.9%
574,148
-6.5%
0.02%
+20.0%
Q3 2022$792,000,000
+39.7%
613,931
-5.8%
0.02%
+87.5%
Q2 2022$567,000,000651,5060.01%
Other shareholders
CONNECT BIOPHARMA HLDGS LTD shareholders Q2 2022
NameSharesValueWeighting ↓
RA Capital Management 6,991,003$36,004,0000.64%
Octagon Capital Advisors LP 279,921$1,442,0000.28%
Altium Capital Management LP 175,000$901,0000.25%
Deep Track Capital, LP 647,057$3,332,0000.24%
Ikarian Capital, LLC 262,237$1,350,0000.20%
Cormorant Asset Management, LP 200,000$1,030,0000.06%
DLD Asset Management, LP 121,707$627,0000.03%
RTW INVESTMENTS, LP 450,000$2,318,0000.03%
ADAGE CAPITAL PARTNERS GP, L.L.C. 1,250,000$6,438,0000.01%
Chicago Partners Investment Group LLC 21,892$97,0000.01%
View complete list of CONNECT BIOPHARMA HLDGS LTD shareholders